OncoTraj: Public Benchmark for Longitudinal Resistance Prediction in EGFR-Mutant NSCLC

arXiv·low signal

Sarkar and Thakur release OncoTraj, a public benchmark for predicting osimertinib resistance trajectories in EGFR-mutant non-small-cell lung cancer, a canonical example of clinically predictable resistance. It is a domain-specific clinical ML benchmark. Off the agent path, noted as a new evaluation resource for medical sequence modeling.